Skip to content

PHMB wound dressings for prevention of wound infections

PHMB wound dressings for prevention of wound infections - PRÄVENT

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030103
Enrollment
264
Registered
2022-11-04
Start date
2022-11-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute and chronic wounds with risk for infection

Interventions

Group 1: Wound dressings of group DracoFoam, observation period 4 weeks, documentation of wound situation every 7 days (+- 2 days). Type of dressing from the group can be chosen by the physician. In c

Sponsors

Dr. Ausbüttel & Co. GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - wound with indication for treatment with a foam dressing - not infected at time point of inclusion - W.A.R. Score >= 3 - written consent of patient - age: >= 18 years - patient can visit on a regular base

Exclusion criteria

Exclusion criteria: - patient not able to consent - patient not able to report adverse events - terminal illness with = 250 cm2 - deep wounds which have to be treated with an additional wound filler

Design outcomes

Primary

MeasureTime frame
Incidence of wound infections per group (aim is infection prevention by Dracofoam Infekt), measured with TILI-Score 2.0; Status of wound is documented every 7 days over 28 days. Dressing changes can be performed at any necessary occasion.

Secondary

MeasureTime frame
Wound size: changes in relative wound area (W.A.R.) in %. Wound situation, changes in: pain (dressing change and general), wound odour, exudate amount, peri-wound skin (reduction of maceration), dressing intervals Prevention of wound infection or need for systemic antibiotics, reduction of stationary hosptial visits Satisfaction of users and patients handling of dressing: ease to use skin compatibility subjective valuation of wound dressing numkber of incidences, severe adverse events, corrective actions, recalls.

Countries

Austria, Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026